BN Dips While Peers Rally — Borrow Market Says No Rush

Short positioning tells a subdued story that stands in sharp contrast to the price action. Short interest at 0.39% of free float is genuinely negligible — there is no meaningful short thesis embedded in the stock. The week-on-week increase of 7.5% and the 37% rise over the past month sound alarming in percentage terms, but the absolute level remains too small to matter; the step-up in shares short reflects mechanical re-rating rather than a building bear conviction. Borrow conditions confirm the same read: availability is completely unconstrained, with over 2.1 billion shares available to lend against fewer than 9 million borrowed. Cost to borrow has actually fallen sharply — down 42% on the week to 0.67% — after a brief spike early in the period that has since unwound. The ORTEX short score of 27.5 ranks in the 85th percentile for low short pressure, meaning shorts are less present here than in roughly 85% of comparable names. None of this looks like a stock under pressure from active short selling.

The Street's positioning reinforces why the underperformance is harder to explain through positioning alone. Analyst consensus is constructive — a recent note cited a mean price target return potential of roughly 14% from current levels — and the factor profile is clean where it matters most for Brookfield's model: the dividend score ranks in the 82nd percentile and days-to-cover ranks 70th. Where the stock looks less compelling is valuation intensity: EV/EBITDA at 36.5x and a P/E near 36x leave limited room for disappointment. The ev/ebit factor score sits at just the 26th percentile, flagging that the market is already paying up relative to operating earnings power. Bulls lean on the diversified fee-bearing capital base spanning infrastructure, real estate, and private equity. Bears focus on the Asset Management segment's performance-fee sensitivity — a softer fundraising or deployment environment compresses the earnings line that justifies the multiple.

The one ownership angle worth noting is insider activity from late June. Director Jack Cockwell sold approximately 269,000 shares across two days at prices in the CAD 61.50–62.37 range, generating roughly USD 11.7 million in proceeds. The Executive Vice Chairman ran a parallel programme over the same period, selling in smaller clips around CAD 62–64. The trades carry a trade significance score of 3 — moderate rather than high — and the net 90-day insider position is actually positive at roughly 604,000 shares on a net basis, suggesting the June selling was more planned disposal than a directional signal. Still, the Cockwell sales were executed within a few percent of current prices, which adds a mild ceiling reference to the short-term chart.

The next event on the calendar is a further earnings disclosure flagged for September 17. With the stock now sitting below the levels at which insiders were selling in June, and with peers running 5–11% higher on the week, what to watch is whether BN closes the gap into the next print or whether the relative underperformance against its alternative-asset peers deepens — and whether the next set of results shows any shift in the performance-fee line that the bear case centres on.